カテゴリー： Market Monitor Global, 世界, 医療/バイオ

バルビツール酸系鎮静剤のグローバル市場展望 2023年-2029年：ショートエフェクト、ミディアムエフェクト、ロングエフェクト、スーパーショートエフェクト

◆英語タイトル：Barbiturate Sedative Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14239）◆商品コード：MMG23DC14239
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：128
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のバルビツール酸系鎮静剤市場規模と予測を収録しています。・世界のバルビツール酸系鎮静剤市場：売上、2018年-2023年、2024年-2029年
・世界のバルビツール酸系鎮静剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバルビツール酸系鎮静剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ショートエフェクト」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

バルビツール酸系鎮静剤のグローバル主要企業は、GlaxoSmithKline、 Astellas Pharma、 Bausch Health Companies、 Teva Pharmaceutical Company、 Pfizer、 Merck、 Eli Lilly、 Mylan N.V、 Sanofi、 Sumitomo Dainippon Pharma、 Oak Pharmaceuticals、 Meda Pharmaceuticals、 Novartis AG、 AstraZeneca、 Johnson & Johnson、 Sun Pharmaceutical Industries Ltd、 Merck & Co., Inc、 Cipla Inc、 Endo International plc、 Torrent Pharmaceuticals Ltd、 Dr. Reddy’s Laboratories Ltd、 Aurobindo Pharma、 Lupin、 Fresenius Kabi AG、 Abbott、 F. Hoffmann-La Roche Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、バルビツール酸系鎮静剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のバルビツール酸系鎮静剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のバルビツール酸系鎮静剤市場：タイプ別市場シェア、2022年
・ショートエフェクト、ミディアムエフェクト、ロングエフェクト、スーパーショートエフェクト

世界のバルビツール酸系鎮静剤市場：用途別、2018年-2023年、2024年-2029年
世界のバルビツール酸系鎮静剤市場：用途別市場シェア、2022年
・睡眠障害、不安神経症、鎮痙、その他

世界のバルビツール酸系鎮静剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のバルビツール酸系鎮静剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるバルビツール酸系鎮静剤のグローバル売上、2018年-2023年
・主要企業におけるバルビツール酸系鎮静剤のグローバル売上シェア、2022年
・主要企業におけるバルビツール酸系鎮静剤のグローバル販売量、2018年-2023年
・主要企業におけるバルビツール酸系鎮静剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline、 Astellas Pharma、 Bausch Health Companies、 Teva Pharmaceutical Company、 Pfizer、 Merck、 Eli Lilly、 Mylan N.V、 Sanofi、 Sumitomo Dainippon Pharma、 Oak Pharmaceuticals、 Meda Pharmaceuticals、 Novartis AG、 AstraZeneca、 Johnson & Johnson、 Sun Pharmaceutical Industries Ltd、 Merck & Co., Inc、 Cipla Inc、 Endo International plc、 Torrent Pharmaceuticals Ltd、 Dr. Reddy’s Laboratories Ltd、 Aurobindo Pharma、 Lupin、 Fresenius Kabi AG、 Abbott、 F. Hoffmann-La Roche Ltd

*************************************************************

・調査・分析レポートの概要
バルビツール酸系鎮静剤市場の定義
市場セグメント
世界のバルビツール酸系鎮静剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバルビツール酸系鎮静剤市場規模
世界のバルビツール酸系鎮静剤市場規模：2022年 VS 2029年
世界のバルビツール酸系鎮静剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバルビツール酸系鎮静剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバルビツール酸系鎮静剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ショートエフェクト、ミディアムエフェクト、ロングエフェクト、スーパーショートエフェクト
バルビツール酸系鎮静剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：睡眠障害、不安神経症、鎮痙、その他
バルビツール酸系鎮静剤の用途別グローバル売上・予測

・地域別市場分析
地域別バルビツール酸系鎮静剤市場規模 2022年と2029年
地域別バルビツール酸系鎮静剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、 Astellas Pharma、 Bausch Health Companies、 Teva Pharmaceutical Company、 Pfizer、 Merck、 Eli Lilly、 Mylan N.V、 Sanofi、 Sumitomo Dainippon Pharma、 Oak Pharmaceuticals、 Meda Pharmaceuticals、 Novartis AG、 AstraZeneca、 Johnson & Johnson、 Sun Pharmaceutical Industries Ltd、 Merck & Co., Inc、 Cipla Inc、 Endo International plc、 Torrent Pharmaceuticals Ltd、 Dr. Reddy’s Laboratories Ltd、 Aurobindo Pharma、 Lupin、 Fresenius Kabi AG、 Abbott、 F. Hoffmann-La Roche Ltd
...

This research report provides a comprehensive analysis of the Barbiturate Sedative Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Barbiturate Sedative Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Barbiturate Sedative Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Barbiturate Sedative Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Barbiturate Sedative Drugs market presents opportunities for various stakeholders, including Sleep Disorder, Anxiety. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Barbiturate Sedative Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Barbiturate Sedative Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Barbiturate sedative drugs have the effects of sedation and hypnosis, anesthesia, antiepileptic, and antispasmodic, but there are also some potential side effects and risks, so it is necessary to strictly follow the doctor’s guidance, and it is necessary to comprehensively consider the patient’s individual condition and the risk of the drug and benefits.
Key Features:
The research report on the Barbiturate Sedative Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Barbiturate Sedative Drugs market.
Market Overview: The report provides a comprehensive overview of the Barbiturate Sedative Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Short Effect, Medium Effect), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Barbiturate Sedative Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Barbiturate Sedative Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Barbiturate Sedative Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Barbiturate Sedative Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Barbiturate Sedative Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Barbiturate Sedative Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Barbiturate Sedative Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Barbiturate Sedative Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Barbiturate Sedative Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Short Effect
Medium Effect
Long Effect
Super-short Effect
Market segment by Application
Sleep Disorder
Anxiety
Antispasmodic (Convulsions)
Others
Global Barbiturate Sedative Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GlaxoSmithKline
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical Company
Pfizer
Merck
Eli Lilly
Mylan N.V
Sanofi
Sumitomo Dainippon Pharma
Oak Pharmaceuticals
Meda Pharmaceuticals
Novartis AG
AstraZeneca
Johnson & Johnson
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Cipla Inc
Endo International plc
Torrent Pharmaceuticals Ltd
Dr. Reddy’s Laboratories Ltd
Aurobindo Pharma
Lupin
Fresenius Kabi AG
Abbott
F. Hoffmann-La Roche Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Barbiturate Sedative Drugs, market overview.
Chapter 2: Global Barbiturate Sedative Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Barbiturate Sedative Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Barbiturate Sedative Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Barbiturate Sedative Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Barbiturate Sedative Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Barbiturate Sedative Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Barbiturate Sedative Drugs Overall Market Size
2.1 Global Barbiturate Sedative Drugs Market Size: 2022 VS 2029
2.2 Global Barbiturate Sedative Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Barbiturate Sedative Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Barbiturate Sedative Drugs Players in Global Market
3.2 Top Global Barbiturate Sedative Drugs Companies Ranked by Revenue
3.3 Global Barbiturate Sedative Drugs Revenue by Companies
3.4 Global Barbiturate Sedative Drugs Sales by Companies
3.5 Global Barbiturate Sedative Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Barbiturate Sedative Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Barbiturate Sedative Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Barbiturate Sedative Drugs Players in Global Market
3.8.1 List of Global Tier 1 Barbiturate Sedative Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Barbiturate Sedative Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Barbiturate Sedative Drugs Market Size Markets, 2022 & 2029
4.1.2 Short Effect
4.1.3 Medium Effect
4.1.4 Long Effect
4.1.5 Super-short Effect
4.2 By Type – Global Barbiturate Sedative Drugs Revenue & Forecasts
4.2.1 By Type – Global Barbiturate Sedative Drugs Revenue, 2018-2023
4.2.2 By Type – Global Barbiturate Sedative Drugs Revenue, 2024-2029
4.2.3 By Type – Global Barbiturate Sedative Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Barbiturate Sedative Drugs Sales & Forecasts
4.3.1 By Type – Global Barbiturate Sedative Drugs Sales, 2018-2023
4.3.2 By Type – Global Barbiturate Sedative Drugs Sales, 2024-2029
4.3.3 By Type – Global Barbiturate Sedative Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Barbiturate Sedative Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Barbiturate Sedative Drugs Market Size, 2022 & 2029
5.1.2 Sleep Disorder
5.1.3 Anxiety
5.1.4 Antispasmodic (Convulsions)
5.1.5 Others
5.2 By Application – Global Barbiturate Sedative Drugs Revenue & Forecasts
5.2.1 By Application – Global Barbiturate Sedative Drugs Revenue, 2018-2023
5.2.2 By Application – Global Barbiturate Sedative Drugs Revenue, 2024-2029
5.2.3 By Application – Global Barbiturate Sedative Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Barbiturate Sedative Drugs Sales & Forecasts
5.3.1 By Application – Global Barbiturate Sedative Drugs Sales, 2018-2023
5.3.2 By Application – Global Barbiturate Sedative Drugs Sales, 2024-2029
5.3.3 By Application – Global Barbiturate Sedative Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Barbiturate Sedative Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Barbiturate Sedative Drugs Market Size, 2022 & 2029
6.2 By Region – Global Barbiturate Sedative Drugs Revenue & Forecasts
6.2.1 By Region – Global Barbiturate Sedative Drugs Revenue, 2018-2023
6.2.2 By Region – Global Barbiturate Sedative Drugs Revenue, 2024-2029
6.2.3 By Region – Global Barbiturate Sedative Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Barbiturate Sedative Drugs Sales & Forecasts
6.3.1 By Region – Global Barbiturate Sedative Drugs Sales, 2018-2023
6.3.2 By Region – Global Barbiturate Sedative Drugs Sales, 2024-2029
6.3.3 By Region – Global Barbiturate Sedative Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Barbiturate Sedative Drugs Revenue, 2018-2029
6.4.2 By Country – North America Barbiturate Sedative Drugs Sales, 2018-2029
6.4.3 US Barbiturate Sedative Drugs Market Size, 2018-2029
6.4.4 Canada Barbiturate Sedative Drugs Market Size, 2018-2029
6.4.5 Mexico Barbiturate Sedative Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Barbiturate Sedative Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Barbiturate Sedative Drugs Sales, 2018-2029
6.5.3 Germany Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.4 France Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.5 U.K. Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.6 Italy Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.7 Russia Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Barbiturate Sedative Drugs Market Size, 2018-2029
6.5.9 Benelux Barbiturate Sedative Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Barbiturate Sedative Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Barbiturate Sedative Drugs Sales, 2018-2029
6.6.3 China Barbiturate Sedative Drugs Market Size, 2018-2029
6.6.4 Japan Barbiturate Sedative Drugs Market Size, 2018-2029
6.6.5 South Korea Barbiturate Sedative Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Barbiturate Sedative Drugs Market Size, 2018-2029
6.6.7 India Barbiturate Sedative Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Barbiturate Sedative Drugs Revenue, 2018-2029
6.7.2 By Country – South America Barbiturate Sedative Drugs Sales, 2018-2029
6.7.3 Brazil Barbiturate Sedative Drugs Market Size, 2018-2029
6.7.4 Argentina Barbiturate Sedative Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Barbiturate Sedative Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Barbiturate Sedative Drugs Sales, 2018-2029
6.8.3 Turkey Barbiturate Sedative Drugs Market Size, 2018-2029
6.8.4 Israel Barbiturate Sedative Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Barbiturate Sedative Drugs Market Size, 2018-2029
6.8.6 UAE Barbiturate Sedative Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Barbiturate Sedative Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Barbiturate Sedative Drugs Major Product Offerings
7.2.4 Astellas Pharma Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 Bausch Health Companies
7.3.1 Bausch Health Companies Company Summary
7.3.2 Bausch Health Companies Business Overview
7.3.3 Bausch Health Companies Barbiturate Sedative Drugs Major Product Offerings
7.3.4 Bausch Health Companies Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bausch Health Companies Key News & Latest Developments
7.4 Teva Pharmaceutical Company
7.4.1 Teva Pharmaceutical Company Company Summary
7.4.2 Teva Pharmaceutical Company Business Overview
7.4.3 Teva Pharmaceutical Company Barbiturate Sedative Drugs Major Product Offerings
7.4.4 Teva Pharmaceutical Company Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceutical Company Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Barbiturate Sedative Drugs Major Product Offerings
7.5.4 Pfizer Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Barbiturate Sedative Drugs Major Product Offerings
7.6.4 Merck Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Barbiturate Sedative Drugs Major Product Offerings
7.7.4 Eli Lilly Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Mylan N.V
7.8.1 Mylan N.V Company Summary
7.8.2 Mylan N.V Business Overview
7.8.3 Mylan N.V Barbiturate Sedative Drugs Major Product Offerings
7.8.4 Mylan N.V Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Mylan N.V Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Barbiturate Sedative Drugs Major Product Offerings
7.9.4 Sanofi Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Sumitomo Dainippon Pharma
7.10.1 Sumitomo Dainippon Pharma Company Summary
7.10.2 Sumitomo Dainippon Pharma Business Overview
7.10.3 Sumitomo Dainippon Pharma Barbiturate Sedative Drugs Major Product Offerings
7.10.4 Sumitomo Dainippon Pharma Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.11 Oak Pharmaceuticals
7.11.1 Oak Pharmaceuticals Company Summary
7.11.2 Oak Pharmaceuticals Business Overview
7.11.3 Oak Pharmaceuticals Barbiturate Sedative Drugs Major Product Offerings
7.11.4 Oak Pharmaceuticals Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Oak Pharmaceuticals Key News & Latest Developments
7.12 Meda Pharmaceuticals
7.12.1 Meda Pharmaceuticals Company Summary
7.12.2 Meda Pharmaceuticals Business Overview
7.12.3 Meda Pharmaceuticals Barbiturate Sedative Drugs Major Product Offerings
7.12.4 Meda Pharmaceuticals Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Meda Pharmaceuticals Key News & Latest Developments
7.13 Novartis AG
7.13.1 Novartis AG Company Summary
7.13.2 Novartis AG Business Overview
7.13.3 Novartis AG Barbiturate Sedative Drugs Major Product Offerings
7.13.4 Novartis AG Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Novartis AG Key News & Latest Developments
7.14 AstraZeneca
7.14.1 AstraZeneca Company Summary
7.14.2 AstraZeneca Business Overview
7.14.3 AstraZeneca Barbiturate Sedative Drugs Major Product Offerings
7.14.4 AstraZeneca Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.14.5 AstraZeneca Key News & Latest Developments
7.15 Johnson & Johnson
7.15.1 Johnson & Johnson Company Summary
7.15.2 Johnson & Johnson Business Overview
7.15.3 Johnson & Johnson Barbiturate Sedative Drugs Major Product Offerings
7.15.4 Johnson & Johnson Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Johnson & Johnson Key News & Latest Developments
7.16 Sun Pharmaceutical Industries Ltd
7.16.1 Sun Pharmaceutical Industries Ltd Company Summary
7.16.2 Sun Pharmaceutical Industries Ltd Business Overview
7.16.3 Sun Pharmaceutical Industries Ltd Barbiturate Sedative Drugs Major Product Offerings
7.16.4 Sun Pharmaceutical Industries Ltd Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.17 Merck & Co., Inc
7.17.1 Merck & Co., Inc Company Summary
7.17.2 Merck & Co., Inc Business Overview
7.17.3 Merck & Co., Inc Barbiturate Sedative Drugs Major Product Offerings
7.17.4 Merck & Co., Inc Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Merck & Co., Inc Key News & Latest Developments
7.18 Cipla Inc
7.18.1 Cipla Inc Company Summary
7.18.2 Cipla Inc Business Overview
7.18.3 Cipla Inc Barbiturate Sedative Drugs Major Product Offerings
7.18.4 Cipla Inc Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Cipla Inc Key News & Latest Developments
7.19 Endo International plc
7.19.1 Endo International plc Company Summary
7.19.2 Endo International plc Business Overview
7.19.3 Endo International plc Barbiturate Sedative Drugs Major Product Offerings
7.19.4 Endo International plc Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Endo International plc Key News & Latest Developments
7.20 Torrent Pharmaceuticals Ltd
7.20.1 Torrent Pharmaceuticals Ltd Company Summary
7.20.2 Torrent Pharmaceuticals Ltd Business Overview
7.20.3 Torrent Pharmaceuticals Ltd Barbiturate Sedative Drugs Major Product Offerings
7.20.4 Torrent Pharmaceuticals Ltd Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Torrent Pharmaceuticals Ltd Key News & Latest Developments
7.21 Dr. Reddy’s Laboratories Ltd
7.21.1 Dr. Reddy’s Laboratories Ltd Company Summary
7.21.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.21.3 Dr. Reddy’s Laboratories Ltd Barbiturate Sedative Drugs Major Product Offerings
7.21.4 Dr. Reddy’s Laboratories Ltd Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Dr. Reddy’s Laboratories Ltd Key News & Latest Developments
7.22 Aurobindo Pharma
7.22.1 Aurobindo Pharma Company Summary
7.22.2 Aurobindo Pharma Business Overview
7.22.3 Aurobindo Pharma Barbiturate Sedative Drugs Major Product Offerings
7.22.4 Aurobindo Pharma Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Aurobindo Pharma Key News & Latest Developments
7.23 Lupin
7.23.1 Lupin Company Summary
7.23.2 Lupin Business Overview
7.23.3 Lupin Barbiturate Sedative Drugs Major Product Offerings
7.23.4 Lupin Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.23.5 Lupin Key News & Latest Developments
7.24 Fresenius Kabi AG
7.24.1 Fresenius Kabi AG Company Summary
7.24.2 Fresenius Kabi AG Business Overview
7.24.3 Fresenius Kabi AG Barbiturate Sedative Drugs Major Product Offerings
7.24.4 Fresenius Kabi AG Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Fresenius Kabi AG Key News & Latest Developments
7.25 Abbott
7.25.1 Abbott Company Summary
7.25.2 Abbott Business Overview
7.25.3 Abbott Barbiturate Sedative Drugs Major Product Offerings
7.25.4 Abbott Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.25.5 Abbott Key News & Latest Developments
7.26 F. Hoffmann-La Roche Ltd
7.26.1 F. Hoffmann-La Roche Ltd Company Summary
7.26.2 F. Hoffmann-La Roche Ltd Business Overview
7.26.3 F. Hoffmann-La Roche Ltd Barbiturate Sedative Drugs Major Product Offerings
7.26.4 F. Hoffmann-La Roche Ltd Barbiturate Sedative Drugs Sales and Revenue in Global (2018-2023)
7.26.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
8 Global Barbiturate Sedative Drugs Production Capacity, Analysis
8.1 Global Barbiturate Sedative Drugs Production Capacity, 2018-2029
8.2 Barbiturate Sedative Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Barbiturate Sedative Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Barbiturate Sedative Drugs Supply Chain Analysis
10.1 Barbiturate Sedative Drugs Industry Value Chain
10.2 Barbiturate Sedative Drugs Upstream Market
10.3 Barbiturate Sedative Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Barbiturate Sedative Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ バルビツール酸系鎮静剤のグローバル市場展望 2023年-2029年：ショートエフェクト、ミディアムエフェクト、ロングエフェクト、スーパーショートエフェクト(Barbiturate Sedative Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 医療用美容薬のグローバル市場展望 2023年-2029年：ダーマフィラー、ボツリヌストキシン、バストインプラント、その他
  • HER2標的薬のグローバル市場展望 2023年-2029年：モノクローナル抗体、低分子化合物、抗体薬物複合体
  • 抗凝血薬のグローバル市場展望 2023年-2029年：ホルモン剤、抗生物質、ACE阻害剤、その他
  • 自閉症スペクトラム（ASD）治療薬のグローバル市場展望 2023年-2029年：自閉症、アスペルガー症候群、小児崩壊性障害、その他
  • 抗放射線薬のグローバル市場展望 2023年-2029年：ヨウ化カリウム（KI）、プルシアンブルー、DTPA（ジエチレントリアミン五酢酸）、その他